Immuneering Corporation (IMRX)

Immuneering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	227.56	36.14	59.41	72.64	74.89	37.09
Short-Term Investments	-	-	26.26	32.89	74.31	-
Cash & Short-Term Investments	227.56	36.14	85.67	105.52	149.2	37.09
Cash Growth	349.22%	-57.81%	-18.82%	-29.27%	302.26%	169.12%
Receivables	-	-	-	0.01	0.25	0.5
Prepaid Expenses	1.54	3.44	3.42	3.21	2.89	0.14
Total Current Assets	229.1	39.59	89.08	108.75	152.33	37.73
Property, Plant & Equipment	4.3	4.79	5.4	5.78	6.13	0.68
Long-Term Investments	-	-	-	-	1	-
Goodwill	6.69	6.69	6.69	6.69	6.7	-
Other Intangible Assets	0.33	0.35	0.38	0.41	0.44	-
Other Long-Term Assets	0.63	1.3	1.03	0.74	0.1	0.01
Total Assets	241.06	52.71	102.58	122.37	166.7	38.42
Accounts Payable	1.6	1.96	2.11	3.15	1.39	1.48
Accrued Expenses	7.48	4.97	5.17	4.5	3.97	0.7
Current Portion of Leases	0.38	0.34	0.3	0.38	0.27	0.08
Other Current Liabilities	0.08	0.23	0.26	0.02	-	-
Total Current Liabilities	9.55	7.5	7.85	8.05	5.63	2.26
Long-Term Leases	3.53	3.82	4.16	4.46	5.09	0.54
Total Liabilities	13.08	11.33	12.01	12.52	10.72	2.8
Common Stock	0.06	0.03	0.03	0.03	0.03	0
Additional Paid-In Capital	496.65	265.65	253.81	219.64	215.28	3.25
Retained Earnings	-268.74	-224.3	-163.26	-109.79	-59.27	-25.74
Comprehensive Income & Other	-	-	-0	-0.03	-0.05	-
Total Common Equity	227.98	41.39	90.58	109.85	155.98	-22.48
Shareholders' Equity	227.98	41.39	90.58	109.85	155.98	35.62
Total Liabilities & Equity	241.06	52.71	102.58	122.37	166.7	38.42
Total Debt	3.92	4.16	4.46	4.84	5.36	0.62
Net Cash (Debt)	223.65	31.98	81.2	100.68	144.83	36.47
Net Cash Growth	381.82%	-60.61%	-19.35%	-30.48%	297.13%	255.02%
Net Cash Per Share	6.29	1.07	2.86	3.82	10.64	7.37
Filing Date Shares Outstanding	64.57	35.89	29.28	26.44	26.38	4.95
Total Common Shares Outstanding	63.48	31.05	29.27	26.42	26.32	4.95
Working Capital	219.56	32.08	81.24	100.69	146.7	35.48
Book Value Per Share	3.59	1.33	3.09	4.16	5.93	-4.54
Tangible Book Value	220.96	34.35	83.51	102.75	148.84	-22.48
Tangible Book Value Per Share	3.48	1.11	2.85	3.89	5.65	-4.54
Machinery	1.92	1.91	1.83	1.5	0.83	0.19
Leasehold Improvements	0.3	0.3	0.3	0.29	0.15	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q